GEO2 Limited has told the Australian Stock Exchange that it has won board approval from IVBH to acquire all of the issued capital of IVBH, which has a major interest in a non-invasive liver diagnosis technology with potentially global applications.

GEO2 Limited has told the Australian Stock Exchange that it has won board approval from IVBH to acquire all of the issued capital of IVBH, which has a major interest in a non-invasive liver diagnosis technology with potentially global applications.